GlassScriptPhysician profile
Meletios S Karas
NPI 1205887098
$1,568.88
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,263 · 2020: $265 · 2021: $40.60.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $182.61 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $168.46 | 2019-2020 | |
| Amgen INC. | $164.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $158.80 | 2019-2020 | |
| Insulet Corporation | $111.23 | 2019-2021 | |
| Pfizer INC. | $84.66 | 2019 | |
| Mannkind Corporation | $74.36 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $72.01 | 2019 | |
| Abbott Laboratories | $71.55 | 2019-2020 | |
| Shire North American Group INC | $58.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.13 | 2019 | |
| Abbvie INC. | $48.81 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.96 | 2019 | |
| Dexcom, INC. | $44.80 | 2019 | |
| Corcept Therapeutics | $39.72 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $32.90 | 2019-2020 | |
| Medtronic Minimed, INC. | $27.31 | 2019 | |
| Lilly USA, LLC | $24.39 | 2019 | |
| Companion Medical, INC. | $16.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.89 | 2019 | |
| Horizon Therapeutics Plc | $15.44 | 2020 | |
| Amarin Pharma, INC. | $14.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.27 | 2019 | |
| Lifescan, INC. | $12.51 | 2020 | |
| Merck Sharp & Dohme LLC | $12.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meletios Karas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.